Incretin Mimetic MDL Court Asked By Plaintiffs To Re-Tax Costs Or Stay Enforcement
(February 26, 2016, 1:27 PM EST) -- SAN DIEGO — Plaintiffs in the incretin mimetic multidistrict litigation on Feb. 25 asked a California federal court to re-tax the $683,440 in costs it awarded to four defendants, to consider rescinding the award altogether or to hold it abeyance while the plaintiffs appeal summary judgment for the defendants (In Re: Incretin-Based Therapies Products Liability Litigation, MDL Docket No. 2452, No. 13-md-2452, S.D. Calif.).